These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15927843)

  • 21. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ixabepilone (Ixempra) for breast cancer.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):7-8. PubMed ID: 18219261
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The plateau in cytotoxic cancer drug discovery.
    Hollander S; Gordon M
    J Med; 1990; 21(3-4):143-63. PubMed ID: 2204674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic principles and clinical pharmacology of cytostatic treatment].
    Schmidt CG
    Verh Dtsch Ges Inn Med; 1980; 86():337-67. PubMed ID: 7223027
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies related to the mechanisms of action of cytotoxic alkylating agents: a review.
    WHEELER GP
    Cancer Res; 1962 Jul; 22():651-88. PubMed ID: 14006445
    [No Abstract]   [Full Text] [Related]  

  • 28. The disposition of cytotoxic drugs in the elderly.
    Wynne H; Woodhouse KW
    Baillieres Clin Haematol; 1987 Jun; 1(2):513-31. PubMed ID: 3322447
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary report on the use of a new cytotoxic drug in the treatment of tumors].
    ROSA L; GIUNGI F; FRANCO T
    Riforma Med; 1957 Jun; 71(22):619-20. PubMed ID: 13454504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Brief review of the pharmacology of cytotoxic agents].
    Logaras G
    Stomatologia (Athenai); 1971; 28(3):157-61. PubMed ID: 5284493
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary clinical experience with E-39, a new drug for advanced cancer.
    FIGUR L; SILVERSTONE SM
    J Mt Sinai Hosp N Y; 1957; 24(5):627-32. PubMed ID: 13476152
    [No Abstract]   [Full Text] [Related]  

  • 32. [Indophenol method, a test for the application of antineoplastic agents].
    Takabe N
    Saishin Igaku; 1969 Aug; 24(8):1798-9. PubMed ID: 5358059
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytotoxic agents.
    Lemon HM; Foley JF
    Practitioner; 1968 Jan; 200(195):158-66. PubMed ID: 5636263
    [No Abstract]   [Full Text] [Related]  

  • 34. The chemical treatment of advanced cancer in man.
    Steinfeld JL
    Natl Cancer Inst Monogr; 1967 Feb; 24():271-89. PubMed ID: 5336279
    [No Abstract]   [Full Text] [Related]  

  • 35. [New antitumor preparations].
    Tiuliandin SA
    Vopr Onkol; 1995; 41(2):131-3. PubMed ID: 7483413
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of cytotoxic agents on iron metabolism.
    Lane M; Alfrey CP; Smith FE
    Cancer Treat Rep; 1985 Jun; 69(6):729-30. PubMed ID: 3926313
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nitrogen mustards, triethylenethiophosphoramide, triethylene melamine & aminopterin in the treatment of advanced cancer].
    GRINBERG R
    Rev Asoc Med Argent; 1959 Apr; 73(4):130-6. PubMed ID: 13658510
    [No Abstract]   [Full Text] [Related]  

  • 38. [Investigation of plant extracts for their cytotoxic and anti-cancer properties].
    PUKHAL'SKAIA ECh; PETROVA MF; MASSAGETOV PS
    Biull Eksp Biol Med; 1957 Jun; 43(6):57-60. PubMed ID: 13488991
    [No Abstract]   [Full Text] [Related]  

  • 39. [The possibilities of treatment with cytostatics and antimetabolites].
    LUHRS W
    Krebsarzt; 1958 Feb; 13(2):63-6. PubMed ID: 13540171
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quantitative relationship of toxicity and anticancerous activity of five preparations from the group of alkylating agents].
    ZHDANOV GL
    Vopr Onkol; 1957; 3(6):678-83. PubMed ID: 13530841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.